T cell receptor gamma variable 2 (TRGV2)

T cell receptor gamma variable 2 (TRGV2) is a protein coding gene encoding the variable (V) region of the gamma chain of the gamma-delta T cell receptor (γδ TCR)[1][3]. This receptor is a disulfide-linked heterodimer composed of a gamma and a delta chain, expressed on a minor subset (~5%) of T lymphocytes called γδ T cells[2][6]. The γδ TCRs are responsible for the recognition of a wide variety of self and foreign non-peptide antigens, often at epithelial boundaries, such as endogenous lipids and phosphoantigens, which are presented by molecules like CD1d and BTN3A1[1][6]. Upon antigen binding, the γδ TCR/CD3 complex signals via phosphorylation cascades that activate T cell effector functions, including rapid, innate-like immune responses crucial for pathogen clearance and tissue repair[1]. Diversity in the γδ TCR repertoire is achieved by V-J (and sometimes D) gene recombination, nucleotide addition, and exonuclease trimming during T cell development, conferring broad antigen specificity[1][5]. While the main clinical/disease associations currently relate to immune response, ongoing research is evaluating γδ TCRs as targets for cancer and infectious disease immunotherapies, but no approved drugs specifically target TRGV2 to date[6].

Other names

VIS2TCRGV2T-cell receptor gamma variable region V2

Drugs targeting γδ T cell receptors may modulate T cell activation and immune response, potentially through agonism or antagonism of antigen recognition or signal transduction.